Medicare Enrolled

Dr. Jessie Coleman, M.D.

Anesthesiology · El Paso, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
3215 GATEWAY BLVD W, El Paso, TX 79903
9155987246
In practice since 2011 (14 years)
NPI: 1174806277 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Coleman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Coleman? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Coleman

Dr. Jessie Coleman is an anesthesiology in El Paso, TX, with 14 years in practice. Based on federal Medicare data, Dr. Coleman performed 8,021 Medicare services across 3,954 unique beneficiaries.

Between the years covered by Open Payments, Dr. Coleman received a total of $23,125 from 39 pharmaceutical and/or device companies across 811 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in anesthesiology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Coleman is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 14 years in practice▲ Top 1% volume in TX$ $23,125 industry payments

Medicare Practice Summary

Medicare Utilization ↗
8,021
Medicare services
Top 1% in TX for anesthesiology
3,954
Unique beneficiaries
$44
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~573 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Dexamethasone injection (steroid)2,596$0$5
Office visit, established patient (30-39 min)703$90$380
Drug screening test538$60$187
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms321$195$597
Comprehensive metabolic blood panel254$10$43
Magnesium level test254$7$27
Phosphate level test254$5$20
Uric acid level test254$4$20
Creatine kinase (cardiac enzyme) level, total252$6$27
Folic acid level test241$14$60
Vitamin B-12 level test238$15$62
Vitamin D level test236$29$111
Complete blood count (CBC) with differential205$8$32
Injection, midazolam hydrochloride, per 1 mg140$0$39
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms118$153$470
Fluoroscopic guidance for needle placement107$84$342
New patient office visit (45-59 min)106$117$534
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms101$110$344
Joint injection, major joint91$47$272
Injection, fentanyl citrate, 0.1 mg71$1$70
Injection, ketorolac tromethamine, per 15 mg66$0$55
Insertion of spinal neurostimulator electrode array through skin61$243$3,766
Injection of substance into lower spine canal using imaging guidance60$182$787
Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level58$231$1,776
Injection of lower or sacral spine facet joint using imaging guidance, single level57$186$1,168
Office visit, established patient (20-29 min)55$64$268
Injection of lower or sacral spine facet joint using imaging guidance, second level54$101$622
Injection of trigger points, 3 or more muscles44$45$205
Cortisol (hormone) measurement, free43$16$68
Hemoglobin A1c test (diabetes monitoring)43$9$40
Complete blood count (CBC), automated37$6$27
Injection, promethazine hcl, up to 50 mg37$2$40
Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint36$474$1,948
Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint35$266$813
Drug injection, under skin or into muscle33$10$50
Injection of upper or middle spine facet joint using imaging guidance, single level27$214$1,312
Injection of upper or middle spine facet joint using imaging guidance, second level26$110$678
Ferritin level test (iron stores)25$12$56
Iron level test25$6$27
Iron binding capacity test25$8$36
Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance18$122$584
Insertion of spinal neurostimulator generator or receiver16$137$1,408
Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint16$471$1,983
Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level15$78$918
Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint15$284$903
Injection of substance into middle or upper spine canal using imaging guidance14$189$798
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$23,125
Total received (2018-2024)
Avg $3,304/year across 7 years
Top 2% in TX for anesthesiology
39
Companies
811
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$23,125 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$4,500
2023
$3,152
2022
$3,246
2021
$3,561
2020
$2,284
2019
$2,471
2018
$3,911

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$18,489
US WorldMeds, LLC
$659
Aurora Spine, Inc.
$625
SCILEX PHARMACEUTICALS INC.
$408
Scilex Pharmaceuticals Inc.
$306
USWM, LLC
$270
PFIZER INC.
$267
Nevro Corp.
$247
Vertos Medical, Inc.
$247
Medtronic, Inc.
$241
Nalu Medical, Inc.
$181
MML US, Inc.
$138
AstraZeneca Pharmaceuticals LP
$134
BOSTON SCIENTIFIC CORPORATION
$104
Horizon Therapeutics plc
$83
Boston Scientific Corporation
$78
Teva Pharmaceuticals USA, Inc.
$73
Lundbeck LLC
$65
GRT US Holding, Inc.
$46
SI-BONE, INC.
$36
Flexion Therapeutics, Inc.
$35
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$33
Pacira Therapeutics, Inc.
$33
Averitas Pharma Inc.
$32
Lilly USA, LLC
$29
Novartis Pharmaceuticals Corporation
$28
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$28
Amgen Inc.
$26
Purdue Pharma L.P.
$25
AbbVie Inc.
$24
ARBOR PHARMACEUTICALS, INC.
$23
Takeda Pharmaceuticals U.S.A., Inc.
$19
ABBVIE INC.
$17
Allergan, Inc.
$17
DePuy Synthes Sales Inc.
$14
Vertiflex, Inc.
$14
BioDelivery Sciences International, Inc.
$12
Allergan Inc.
$12
FIDIA PHARMA USA INC.
$9
Top 3 companies account for 85.5% of total payments
Associated products mentioned in payments ›
AIMOVIG · AJOVY · AXIUM · Amitiza · Axium INS DRG IPG · Axium Sheath Braided DRG · BELBUCA · BOTOX · DRG IPGs · DRG leads · EMGALITY · ETERNA · Horizant · Hymovis · INTELLIS ADAPTIVESTIM · IONICRF · LYBREL · LYRICA · Lucemyra · Lucemyra/Lofexidine · MOVANTIK · NT1100 NT2000iX Simplicity · Nalu Neurostimulation System · OCTRODE · ORTHOVISC · Octrode SCS Leads · PENNSAID · PROCLAIM · Penta SCS Leads · Proclaim DRG IPG · Proclaim Family of SCS IPGs · Proclaim IPG · Prodigy Family of SCS IPGs · Protege Family of SCS IPGs · QULIPTA · QUTENZA · Qutenza · Radiofrequency Therapy · ReActiv8 · SCS IPGs · SCS leads · SYMJEPI · SYMPROIC · Senza · Superion · Superion ISS · UBRELVY · VYEPTI · WaveWriter Alpha Prime 16 · XIFAXAN · ZIMHI · ZIP · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zilretta · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 2% for anesthesiology in TX.

Equivalent to $288 per 100 Medicare services performed
Looking for a anesthesiology in El Paso?
Compare anesthesiologys in the El Paso area by procedure volume, costs, and industry payment transparency.
Browse anesthesiologys nearby

Geographic Context

Anesthesiologys within 10 mi
71
Per 100K population
8.2
County median income
$58,859
Nearest hospital
UNIVERSITY MEDICAL CENTER OF EL PASO
1.7 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Coleman is a mixed practice specialist, with above-average Medicare volume (top 1% in TX), and high industry engagement (low-engagement, top 2%).

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Coleman experienced with dexamethasone injection (steroid)?
Based on Medicare claims data, Dr. Coleman performed 2,596 dexamethasone injection (steroid) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Coleman receive payments from pharmaceutical companies?
Yes. Dr. Coleman received a total of $23,125 from 39 companies across 811 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Coleman's costs compare to other anesthesiologys in El Paso?
Dr. Coleman's average Medicare payment per service is $44. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Coleman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →